高级检索
当前位置: 首页 > 详情页

Memory CD4(+) T cells are suppressed by CD8(+) regulatory T cells in vitro and in vivo

| 导出 |

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

单位: [1]Hepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China [2]Department of Microbiology and Immunology, Medical University of South Carolina, Charleston, SC 29466, USA
出处:
ISSN:

关键词: Qa-1 T regulatory cells (Tregs) memory T cells transplantation

摘要:
Background: Acute graft rejection mediated by alloreactive memory CD4(+) T cells is a major obstacle to transplantation tolerance. It has been reported that CD8(+) T regulatory cells (Tregs) have the ability to induce graft tolerance by restraining the function of activated CD4(+) T cells, but not including memory T cells. The aim of this study is to elucidate the effect of CD8+ Tregs on alloreactive memory CD4(+) T cells. Methods: We detected Qa-1 expression and performed proliferative assay on memory CD4(+) T cells. All memory CD4(+) T cells were purified from mice receiving skin allografts. We performed inhibitory and cytotoxic assays on CD8(+) Tregs, which were isolated from a T cell vaccination mouse model, and IL-2, IL-4, IL-10 and IFN-gamma levels were measured in co-culture supernatants by ELISA. To confirm CD8(+) Tregs inhibition of memory CD4(+) T cells in-vivo, we utilized a murine model of cardiac allograft transplantation. Results: Memory CD4(+) T cells mediated acute allograft rejection, and CD8(+) Tregs suppressed the proliferation of memory CD4(+) T cells. In vitro, memory CD4(+) T cells were inhibited and lysed by CD8(+) Tregs. There was a positive correlation between IFN-gamma levels, and cell lysis rate induced by CD8(+) Tregs. In-vivo studies demonstrated CD8(+) Tregs prolonged graft survival times, by inhibiting CD4(+) memory T cells, through a Qa-1-peptide-TCR pathway. Conclusions: CD8(+) Tregs inhibit CD4(+) memory T cell-mediated acute murine cardiac allograft rejection, and further prolong graft survival times. These results provide new insights into immune regulation of organ rejection.

基金:

基金编号: 81001305

语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2016]版:
大类 | 3 区 医学
小类 | 3 区 医学:研究与实验 3 区 肿瘤学
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 医学:研究与实验 4 区 肿瘤学
JCR分区:
出版当年[2015]版:
Q2 ONCOLOGY Q2 MEDICINE, RESEARCH & EXPERIMENTAL
最新[2023]版:
Q3 MEDICINE, RESEARCH & EXPERIMENTAL Q4 ONCOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2015版] 出版当年五年平均 出版前一年[2014版] 出版后一年[2016版]

第一作者:
第一作者单位: [1]Hepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
共同第一作者:
通讯作者:
通讯机构: [1]Hepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China [*1]Hepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Wuhan 430030, Hubei Province, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:426 今日访问量:0 总访问量:410 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)